Sandy Spring Bank decreased its position in shares of Monsanto (NYSE:MON) by 1.9% in the fourth quarter, Holdings Channel reports. The fund owned 27,814 shares of the basic materials company’s stock after selling 526 shares during the period. Sandy Spring Bank’s holdings in Monsanto were worth $3,248,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other institutional investors have also recently added to or reduced their stakes in the business. Scotia Capital Inc. increased its holdings in shares of Monsanto by 1.6% during the 2nd quarter. Scotia Capital Inc. now owns 3,765 shares of the basic materials company’s stock worth $446,000 after purchasing an additional 60 shares during the period. Raymond James Financial Services Advisors Inc. increased its holdings in shares of Monsanto by 0.9% during the 2nd quarter. Raymond James Financial Services Advisors Inc. now owns 42,401 shares of the basic materials company’s stock worth $5,019,000 after purchasing an additional 365 shares during the period. Moors & Cabot Inc. increased its holdings in shares of Monsanto by 6.5% during the 2nd quarter. Moors & Cabot Inc. now owns 6,252 shares of the basic materials company’s stock worth $744,000 after purchasing an additional 382 shares during the period. Parkside Financial Bank & Trust increased its holdings in shares of Monsanto by 10.2% during the 3rd quarter. Parkside Financial Bank & Trust now owns 4,865 shares of the basic materials company’s stock worth $583,000 after purchasing an additional 452 shares during the period. Finally, Laurel Wealth Advisors Inc. increased its holdings in shares of Monsanto by 12.2% during the 3rd quarter. Laurel Wealth Advisors Inc. now owns 4,166 shares of the basic materials company’s stock worth $499,000 after purchasing an additional 453 shares during the period. 75.62% of the stock is owned by hedge funds and other institutional investors.
MON has been the topic of several research reports. Zacks Investment Research downgraded shares of Monsanto from a “buy” rating to a “hold” rating in a report on Monday, December 11th. Deutsche Bank restated a “buy” rating on shares of Monsanto in a report on Tuesday, January 16th. Wells Fargo & Co restated a “market perform” rating and set a $128.00 price objective (up previously from $118.00) on shares of Monsanto in a report on Wednesday, January 17th. Finally, Royal Bank of Canada restated a “hold” rating and set a $128.00 price objective on shares of Monsanto in a report on Wednesday, November 15th. Eleven investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. The stock currently has a consensus rating of “Hold” and a consensus price target of $127.30.
In related news, EVP Steven Mizell sold 8,100 shares of the company’s stock in a transaction dated Tuesday, January 9th. The shares were sold at an average price of $119.35, for a total value of $966,735.00. Following the sale, the executive vice president now owns 56,743 shares of the company’s stock, valued at $6,772,277.05. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Insiders own 0.70% of the company’s stock.
Shares of Monsanto (NYSE MON) opened at $121.00 on Monday. The firm has a market cap of $53,336.90, a PE ratio of 21.12, a P/E/G ratio of 1.73 and a beta of 1.01. Monsanto has a 52 week low of $106.97 and a 52 week high of $123.15. The company has a debt-to-equity ratio of 1.05, a current ratio of 1.28 and a quick ratio of 0.79.
Monsanto (NYSE:MON) last posted its earnings results on Thursday, January 4th. The basic materials company reported $0.41 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.42 by ($0.01). The business had revenue of $2.66 billion during the quarter, compared to the consensus estimate of $2.77 billion. Monsanto had a net margin of 16.38% and a return on equity of 40.13%. The business’s revenue was up .3% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.21 EPS. equities analysts expect that Monsanto will post 5.76 EPS for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Friday, April 27th. Investors of record on Friday, April 6th will be paid a $0.54 dividend. The ex-dividend date of this dividend is Thursday, April 5th. This represents a $2.16 dividend on an annualized basis and a yield of 1.79%. Monsanto’s payout ratio is currently 39.85%.
COPYRIGHT VIOLATION WARNING: This news story was first reported by Stock Observer and is owned by of Stock Observer. If you are reading this news story on another publication, it was illegally stolen and reposted in violation of international copyright & trademark laws. The correct version of this news story can be viewed at https://www.thestockobserver.com/2018/02/05/monsanto-mon-shares-sold-by-sandy-spring-bank.html.
Monsanto Company Profile
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Want to see what other hedge funds are holding MON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Monsanto (NYSE:MON).
Receive News & Ratings for Monsanto Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto and related companies with MarketBeat.com's FREE daily email newsletter.